After the government unveiled a plan to inoculate 10 million high-risk people by July
Reuters
January 28, 2021
People wearing masks stand before a zebra crossing on a cold winter day amid the coronavirus disease (Covid-19) pandemic in Seoul, South Korea, January 7, 2021. PHOTO: REUTERS
SEOUL:
South Korea will review the use of AstraZeneca’s Covid-19 vaccine for the elderly because of limited efficacy data, the government said on Thursday, as it unveiled a plan to inoculate 10 million high-risk people by July.
Vaccinations will be expanded towards the second half of the year to include the general public with a goal of reaching herd immunity by November, Korea Disease Control and Prevention Agency (KDCA) director Jeong Eun-kyeong told a news briefing.